• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

NYU Langone Researchers Use ResearchKit App to Track Concussions

by Fred Pennic 12/17/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

NYU Langone Concussion Tracker app for iPhone, WatchThis week, Researchers at NYU Langone Medical Center unveiled the NYU Langone Concussion Tracker app for iPhone and Apple Watch that can track concussions during the critical six week following their diagnosis. Created by clinicians and IT experts at NYU Langone, the app offers a new way to engage patients in studies that use digital tools to shape clinical care. 

The NYU Langone Concussion Tracker app will be used to track patient-reported symptoms during the six-week recovery period. Initial treatment usually includes rest, but experts want better, research-based measures of how much rest or activity is needed, or why some patients recover faster.

Study Details

Participants in the study will complete three daily tasks: a five-question survey that captures symptoms, including balance issues, blurred vision, and drowsiness; a six-minute walk test; and tasks to measure concentration. The NYU Langone Concussion Tracker app is now available in Apple’s App Store. Researchers hope the app will provide a more in-depth, daily picture of concussion nationwide. 

The study uses the new ResearchKit software framework designed by Apple to make it easier for researchers to gather data more frequently and more accurately from participants using iPhone, as well as for individuals to take part in studies by using their mobile devices. ResearchKit enables participants to easily complete tasks or submit surveys right from the app and delivers a simple way to present participants with an interactive informed consent process. 

“By tracking these measurements among concussion patients on a daily basis, instead of every one to two weeks at their appointments, this app and the related research project will let us assess current treatment protocols in ways not before possible, including greater understanding of how a patients concussion symptoms improve over the course of their recovery,“ said Paul Testa, MD, chief medical information officer at NYU Langone who is also a study investigator.

All study participant information will automatically be de-identified and stored in a secure database, where it will be reviewed for research purposes only.

Also part of this study, a separate group of 100 volunteers over the age of 18 will be recruited by NYU Langone’s Concussion Center to come in for six weeks and complete the questionnaire and tasks in person using the app in the presence of a research coordinator. This data will be stored in NYU Langone’s patient electronic health record (EHR)system, allowing patients to view their results in their MyChart account.

Participants who do not have an iPhone and Apple Watch will receive a borrowed set that is returned at the completion of the study. This part of the study will be led by Dennis A. Cardone, DO, co- PI, and associate professor of orthopaedic surgery.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Apple ResearchKit

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |